Skip to main content
C

Curida

The startup operates a contract development and manufacturing organization that specializes in the production of liquid medicines using unit-dose Blow-Fill-Seal technology, which minimizes human intervention and enhances product consistency. By providing reliable pharmaceutical products, including nasal sprays and bottled solutions, the company ensures healthcare providers have access to tested and quality medications for their patients.

Updated 2 months ago

Funding

$35.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

SH
Funding rounds are not available yet.

Founders

Product

Features

  • The startup operates a contract development and manufacturing organization that specializes in the production of liquid medicines using unit-dose Blow-Fill-Seal technology, which minimizes human intervention and enhances product consistency. By providing reliable pharmaceutical products, including nasal sprays and bottled solutions, the company ensures healthcare providers have access to tested and quality medications for their patients.
This profile is AI-generated and may contain inaccuracies.